Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H22ClFN6O2 |
| Molecular Weight | 432.879 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=C(C=C(Cl)C(F)=C1[C@@H]2CNC(=O)C2)[C@H](C)N3N=C(C)C4=C3N=CN=C4N
InChI
InChIKey=ZQPDJCIXJHUERQ-QWRGUYRKSA-N
InChI=1S/C20H22ClFN6O2/c1-4-30-18-12(6-13(21)17(22)16(18)11-5-14(29)24-7-11)10(3)28-20-15(9(2)27-28)19(23)25-8-26-20/h6,8,10-11H,4-5,7H2,1-3H3,(H,24,29)(H2,23,25,26)/t10-,11-/m0/s1
| Molecular Formula | C20H22ClFN6O2 |
| Molecular Weight | 432.879 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
793 nM |
10 mg single, oral dose: 10 mg route of administration: Oral experiment type: SINGLE co-administered: |
PARSACLISIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
954 nM |
10 mg single, oral dose: 10 mg route of administration: Oral experiment type: SINGLE co-administered: Itraconazole |
PARSACLISIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
1650 nM CLINICAL TRIAL https://pubmed.ncbi.nlm.nih.gov/32515832/ |
20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered: |
PARSACLISIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
7500 nM × h |
10 mg single, oral dose: 10 mg route of administration: Oral experiment type: SINGLE co-administered: |
PARSACLISIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
15600 nM × h |
10 mg single, oral dose: 10 mg route of administration: Oral experiment type: SINGLE co-administered: Itraconazole |
PARSACLISIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
14800 nM × h CLINICAL TRIAL https://pubmed.ncbi.nlm.nih.gov/32515832/ |
20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered: |
PARSACLISIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
13.2 h |
10 mg single, oral dose: 10 mg route of administration: Oral experiment type: SINGLE co-administered: |
PARSACLISIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
21.1 h |
10 mg single, oral dose: 10 mg route of administration: Oral experiment type: SINGLE co-administered: Itraconazole |
PARSACLISIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
14.7 h CLINICAL TRIAL https://pubmed.ncbi.nlm.nih.gov/32515832/ |
20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered: |
PARSACLISIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
5.8% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31749910/ |
unknown, unknown |
PARSACLISIB plasma | Homo sapiens population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:38:16 GMT 2025
by
admin
on
Mon Mar 31 22:38:16 GMT 2025
|
| Record UNII |
OS7097575K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
707319
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
||
|
FDA ORPHAN DRUG |
758420
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
||
|
FDA ORPHAN DRUG |
703919
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
||
|
FDA ORPHAN DRUG |
688519
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
||
|
FDA ORPHAN DRUG |
707419
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
||
|
FDA ORPHAN DRUG |
932023
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
||
|
FDA ORPHAN DRUG |
688319
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10589
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
PRIMARY | |||
|
OS7097575K
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
PRIMARY | |||
|
C113434
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
PRIMARY | |||
|
1426698-88-5
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
PRIMARY | |||
|
100000177914
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
PRIMARY | |||
|
FG-213
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
PRIMARY | |||
|
DB14867
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
PRIMARY | |||
|
86677874
Created by
admin on Mon Mar 31 22:38:16 GMT 2025 , Edited by admin on Mon Mar 31 22:38:16 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
OFF TARGET->NON-INHIBITOR |
IC50
|
||
|
TARGET -> INHIBITOR | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
OFF TARGET->NON-INHIBITOR |
IC50
|
||
|
OFF TARGET->NON-INHIBITOR |
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |